Tandem Diabetes Care (TNDM) Operating Margin (2013 - 2026)
Tandem Diabetes Care (TNDM) reported Operating Margin of 7.05% for Q1 2026, up 4451.0% on a YoY basis from 0.15% in Q1 2025, and down 346.9% quarter-over-quarter from 2.86% in Q4 2025.
Tandem Diabetes Care (TNDM) Operating Margin (2013 - 2026) Analysis & Trends
Tandem Diabetes Care has reported Operating Margin for 14 years, with the latest figure at 7.05% in Q1 2026.
- For the quarter ending Q1 2026, Operating Margin rose 4451.0% year-over-year to 7.05%; the trailing twelve-month figure through Mar 2026 stood at 8.16% (up 999.0% YoY), and the FY2025 full-year result was 18.45%, down 791.0% from the prior year.
- Operating Margin for Q1 2026 stood at 7.05%, down from 2.86% in the prior quarter.
- The five-year high for Operating Margin was 2.86% in Q4 2025, with the low at 75.46% in Q1 2023.
- Historically, Operating Margin has averaged 18.19% across 5 years, with a median of 13.87% in 2024.
- Annual changes were most pronounced in 2023 — Operating Margin sank 6674 bps — and 2024, when it surged 5372 bps.
- Tandem Diabetes Care's Operating Margin stood at 8.06% in 2022, then tumbled by 121 bps to 17.82% in 2023, then surged by 99 bps to 0.21% in 2024, then surged by 1490 bps to 2.86% in 2025, then sank by 347 bps to 7.05% in 2026.
- The last three Operating Margin figures came in at 7.05% (Q1 2026), 2.86% (Q4 2025), and 9.17% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Tandem Diabetes Care | 1.04 Bn | 474.17 Mn | 136.79 Mn | -7.05% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.05% |
| Dec 31, 2025 | 2.86% |
| Sep 30, 2025 | -9.17% |
| Jun 30, 2025 | -21.53% |
| Mar 31, 2025 | -51.56% |
| Dec 31, 2024 | -0.21% |
| Sep 30, 2024 | -10.70% |
| Jun 30, 2024 | -13.87% |
| Mar 31, 2024 | -21.74% |
| Dec 31, 2023 | -17.82% |
| Sep 30, 2023 | -16.99% |
| Jun 30, 2023 | -19.81% |
| Mar 31, 2023 | -75.46% |
| Dec 31, 2022 | -8.06% |
| Sep 30, 2022 | -23.22% |
| Jun 30, 2022 | -6.11% |
| Mar 31, 2022 | -8.72% |
| Dec 31, 2021 | 6.07% |
| Sep 30, 2021 | 4.30% |
| Jun 30, 2021 | 3.16% |